Faster time to clinical candidate using FEP activity prediction now universally available in Flare™ V3

Dec 03, 2019

Posted by Cresset

Perspectives on Gene Therapy: Defining and Demonstrating Value to Payers

Nov 27, 2019

Flare™ V3 release features fully validated and accessible FEP calculations and new workflows

Nov 26, 2019

Posted by Cresset

You have a crystal structure, but what do you do with it and how do you use it?

Nov 26, 2019

Posted by Cresset

2019 MassBio Industry Snapshot

Nov 26, 2019

Tunnell Consulting Announces Ricardo (Rick) Ruiz’s Appointment as Principal

Nov 22, 2019

Posted by Tunnell Consulting

Pragmatic Randomized Trials: Considerations for Design and Implementation

Nov 20, 2019

Delivering on the Promise of Cell Therapy: Challenges and Trends

Nov 20, 2019

Cresset and Liverpool ChiroChem announce collaboration to curate cost effective, novel and highly diverse compound libraries

Nov 20, 2019

Posted by Cresset